Ligand profile
XT8
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_1865 — penicillin-binding protein 2
Identifiers
Database identifiers and provenance.
- Ligand ID
XT8- PDB
6un3- UniProt (similar protein)
G3XD46- Target protein
- VK055_1865
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 132.8
- −1 ≤ LogP ≤ 5 0.49
- MW ≤ 500 Da 386.5
- LogP ≤ 5 0.49
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 7
- TPSA ≤ 140 Ų 132.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC1([C@@H](N[C@H](S1)[C@@H](C=O)NC(=O)[C@@H](c2ccsc2)C(=O)O)C(=O)O)CCC1([C@@H](N[C@H](S1)[C@@H](C=O)NC(=O)[C@@H](c2ccsc2)C(=O)O)C(=O)O)C
InChI=1S/C15H18N2O6S2/c1-15(2)10(14(22)23)17-12(25-15)8(5-18)16-11(19)9(13(20)21)7-3-4-24-6-7/h3-6,8-10,12,17H,1-2H3,(H,16,19)(H,20,21)(H,22,23)/t8-,9-,10+,12-/m1/s1InChI=1S/C15H18N2O6S2/c1-15(2)10(14(22)23)17-12(25-15)8(5-18)16-11(19)9(13(20)21)7-3-4-24-6-7/h3-6,8-10,12,17H,1-2H3,(H,16,19)(H,20,21)(H,22,23)/t8-,9-,10+,12-/m1/s1
GQZADNJRZOHJDT-MWGHHZFTSA-NGQZADNJRZOHJDT-MWGHHZFTSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00905
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand XT8 →
- PDB RCSB structure 6un3 →
- UniProt UniProt G3XD46 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “XT8”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_1865.
PDB 24
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 4
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).